Searchable abstracts of presentations at key conferences in endocrinology

ea0031p172 | Neoplasia, cancer and late effects | SFEBES2013

Gut carcinoid in a patient with horseshoe kidney and family history of carcinoid syndrome: a case report

Lois Konstantinos , James Andy , Perros Petros

Introduction: The familial risks of carcinoids are not clear. There has never been a report of gastrointestinal carcinoid coexisting with horseshoe kidney.Case presentation: We present the case of a 15 mm well differentiated metastatic small bowel NET with vascular and perineural invasion and three of four positive lymph nodes (Ki67: 1.9%, ENETS stage: pT4 pN1 pMX R1) in a 75-year-old British male with episodes of diarrhea and 24 h urinary 5HIAA: 48 (&#6...

ea0028p348 | Thyroid | SFEBES2012

Post-radioiodine management of patients with Graves’ disease

Collins Katherine , Perros Petros , Horsfield Julia

Background: Radioiodine is a safe and effective treatment for Graves’ disease. Iatrogenic hypothyroidism is very common after treatment, but its onset is unpredictable. Even a short episode of hypothyroidism can result in significant morbidity and ideally should be avoided. In our centre a standard dose of radioiodine (400 MBq) is used, but for historical reasons two different protocols are used after radioiodine: Regimen A: regular clinical and biochemical monitoring and...

ea0018p1 | (1) | MES2008

Can random urinary 5-hydroxyindolacetic acid/creatinine results and 24 hour urinary 5-hydoxyindolacetic acid levels predict carcinoid patient survival?

May Simon , Peaston Robert , Perros Petros

The use of 24 h urinary 5-hydroxyindolacetic acid (5-HIAA) concentrations to detect carcinoid patients is a well established procedure while random urinary 5-hydroxyindolacetic acid/creatinine ratio (5-HIAA/cr) may also offer a simpler approach in the diagnosis of carcinoid tumours. However, there is uncertainty regarding the ability of these tests to offer a prognostic indicator for patients.We retrospectively reviewed the initial paired urinary 5-HIAA/...

ea0018p2 | (1) | MES2008

A comparsion of random urinary 5-hydroxyindolacetic acid/creatinine results with 24 hour urinary 5-hydroxyindolacetic acid values in carcinoid patients

May Simon , Peaston Robert , Perros Petros

Although 24 h urinary 5-hydroxyindolacetic acid (5-HIAA) concentration is a well established test for the detection and monitoring of carcinoid tumours, compliance, adequacy of collection and the influence of dietary sources of serotonin are problems associated with this approach. Recently, a random urinary 5-hydroxyindolacetic acid creatinine ratio (R/5-HIAA/cr) test has become available which can be used in outpatient departments, however its correlation to 24 h 5-HIAA (24/5...

ea0044cc3 | Featured Clinical Cases | SFEBES2016

Tremelimumab-induced Graves’ disease

Gan Earn H , Plummer Ruth , Pearce Simon , Perros Petros

Ipilimumab and tremelimumab are monoclonal antibodies directed against the extracellular domain of cytotoxic T-lymphocyte-associated antigen 4 (CTLA4) and have been used as the immunotherapies against immune checkpoints that suppress T cell activation. These anti-CTLA4 antibody-based therapies are effective in treating various cancers including metastatic melanoma. However, a few immune-related adverse events including hypophysitis and transient thyroiditis have been reported....

ea0059p210 | Thyroid | SFEBES2018

Weight gain with hyperthyroidism therapy: a prospective pilot study

Kyriacou Angelos , Kyriacou Alexis , Syed Akheel A , Perros Petros

Introduction: It is currently unclear how hyperthyroidism and its treatment impact on the weight trajectory of an individual. Anticipated weight gain with the treatment of hyperthyroidism is one of the main concerns of patients.Methods: We prospectively examined the BMI changes that occurred with hyperthyroidism and its therapy and sought risk factors for treatment-related weight gain. An established institutional protocol for the management of hyperthyr...

ea0015p50 | Clinical practice/governance and case reports | SFEBES2008

Assessment of optimum hydrocortisone replacement therapy in patients with adrenal insufficiency

Woods David , Chandran Sukesh , Birchall Daniel , Perros Petros

Introduction: The commonest cause of orbitopathy is Graves’ disease but the differential diagnosis includes primary and secondary neoplasia, inflammatory, vascular and infective causes. We report an exceedingly rare case of orbitopathy as the presenting feature of Acromegaly.Case report: A 43 year old lady presented with ‘periorbital puffiness’ and irritable eyes. Clinical evaluation revealed orbitopathy and magnetic resonance imaging (MRI...

ea0015p368 | Thyroid | SFEBES2008

Patient perception of aetiology of Graves’ orbitopathy

Vamvini Maria , Morris Margaret , Dickinson A Jane , Perros Petros

Introduction: The aetiology of Graves’ orbitopathy (GO) is complex and includes genetic and environmental influences. Among potentially controllable risk factors smoking ranks highest. There is strong evidence that smoking cessation benefits patients with GO. The success of secondary prevention strategies depends largely on how the intervention is perceived by patients, especially when it involves lifestyle changes.Objectives: To determine patient p...

ea0015p378 | Thyroid | SFEBES2008

Specificity of first-line tests for the diagnosis of Graves’ disease: assessment in a large series of hyperthyroid patients

Razvi Salman , Perros Petros , Parr John , Wahid Shahid

Context: Hyperthyroidism is a common endocrine condition that can be associated with significant morbidity. It is important to ascertain the underlying cause of hyperthyroidism as the natural history, potential complications and response to treatment can be very different.Objective: To investigate if measurement of TSH-receptor binding inhibitory immunoglobulin (TBII), a TSH-receptor antibody found in Graves disease, in the serum of newly diagnosed hyper...

ea0055wh5 | Workshop H: Miscellaneous endocrine and metabolic disorders | SFEEU2018

NET or Not? A case illustrating potential difficulties in detecting neuroendocrine tumours

Tee Su Ann , James Robert Andrew , Petrides George , Allcock Robert , Perros Petros

A 68-year-old lady presented with a right-sided breast lump detected on routine mammography. Past medical history included type 2 diabetes, asthma, and hypothyroidism following radioactive iodine for toxic multinodular goitre. Staging CT showed 2 presumed metastases in the left lung, and one in the right lung. She was referred for biopsy and/or resection of these lesions. Histology of the left lower lobe lesion showed a typical carcinoid tumour with an adjacent neuroendocrine ...